Dynamic Changes,Correlation of Basophils,and the Therapeutic Effect in Patients With Allergic Rhinitis During Allergen-specific Immunotherapy

Abstract

Background

The role of basophils in allergic rhinitis (AR) has been studied extensively; however, there are very few reports on changes in basophils after allergen-specific immunotherapy (SIT).

Objective

To examine the changes and correlation of peripheral blood basophils and the therapeutic effect in patients with AR during allergen-SIT.

Methods

A total of 77 patients with AR who were allergic only to house dust mites received allergen-SIT. At 3 time points, patients underwent testing for the percentage and activation rate of basophils in peripheral blood, skin index (SI) measurement, visual analog scale (VAS) assessment, and rhinoconjunctivitis quality of life questionnaire (RQLQ) evaluation. The results were compared to a control group with congenital preauricular fistula.

Results

(1) Before treatment, the percentage and activation rate of basophils in patients with AR were significantly higher than those in controls. There was no significant difference in the percentages and activation rates of basophils at the 3 time points. (2) The SIs, VAS, and RQLQ scores of the patients immediately after treatment and 2 years posttreatment decreased significantly compared to those before treatment; the SI, VAS, and RQLQ scores of the patients 2 years posttreatment increased significantly compared with those immediately after treatment. (3) There was no correlation between the patients’ basophil activation rate and percentage and the SI, VAS, and RQLQ scores at all time points.

Conclusion

The percentage and activation rate of basophils were higher in patients with AR than in controls. The values did not change significantly after allergen-SIT and showed no correlation with treatment effectiveness. Therefore, the frequency and activation rate of basophils cannot be used as criteria for assessing the effectiveness of allergen-SIT for house dust mites. Allergen-SIT is effective for the management of AR, but the effect declines after the completion of therapy.

Keywords

basophils allergic rhinitis allergen-specific immunotherapy visual analog scale rhinoconjunctivitis quality of life questionnaire skin index peripheral blood congenital preauricular fistula activation rate rhinoconjunctivitis

Get full access to this article

View all access options for this article.

References

Karasuyama

Mukai

Tsujimura

, et al. Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev Immunol. 2009;9(1):9–13. doi:10.1038/nri2458

Falcone

Zillikens

Gibbs

. The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp Dermatol. 2006;15(11):855–864. doi:10.1111/j.1600-0625.2006.00477.x

Seidman

Gurgel

Lin

, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1Suppl):S1–S43. doi:10.1177/0194599814561600

Jutel

Agache

Bonini

, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556–568. doi:10.1016/j.jaci.2015.04.047

Zhang

Sun

Han

. Allergen-specific subcutaneous immunotherapy. Chin J Otorhinolaryngol Head Neck Surg. 2011;46(12):1063–1068. doi:10.3760/cma.j.issn.1673-0860

Song

Lin

Chai

. Evaluation of long-term effect for house dust mite subcutaneous immunotherapy for patients with allergic rhinitis. Chin J Otorhinolaryngol Head Neck Surg. 2015;50(8):632–635.

Naclerio

Proud

Moylan

, et al. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997;100(3):293–300. doi:10.1016/s0091-6749(97)70240-9

Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery; Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. Guidelines for diagnosis and treatment of allergic rhinitis (2016, Tianjin). Chin J Otorhinolaryngol Head Neck Surg. 2016;51(1):6–24. doi:10.3760/cma.j.issn.1673-0860

Dietz de Loos

Segboer

Gevorgyan

, et al. Disease-specific quality-of-life questionnaires in rhinitis and rhinosinusitis: review and evaluation. Curr Allergy Asthma Rep. 2013;13(2):162–170. doi:10.1007/s11882-012-0334-8

10.

Zhang

Wang

Han

. Significance of skin test and specific IgE examination in the diagnosis of pediatric allergic rhinitis. Chin J Otorhinolaryngol Head Neck Surg. 2011;46(1):12–14. doi:10.3760/cma.j.issn.1673-0860

11.

McGowan

Saini

. Update on the performance and application of basophil activation tests. Curr Allergy Asthma Rep. 2013;13(1):101–109. doi:10.1007/s11882-012-0324-x

12.

Blumberga

Groes

Dahl

. SQ-standardized house dust mite immunotherapy as all immunomodulatory treatment in patients with asthma. Allergy. 201l;66(2):178–185. doi:10.1111/j.1398-9995.2010.02451.x

13.

Hida

Yamasaki

Sakamoto

, et al. Fc receptor gamma chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils. Nat Immunol. 2009;10(2):214–222. doi:10.1038/ni.1686

14.

Sokol

Medzhitov

. Role of basophils in the initiation of Th2 responses. CurrOpin Immunol. 2010;22(1):73–77. doi:10.1016/j.coi.2010.01.012

15.

Saini

Bloom

Bieneman

, et al. Systemic effects of allergen exposure on blood basophil IL-13secretion and FcepsilonRIbeta. J Allergy Clin Immunol. 2004;114(4):768–774. doi:10.1016/j.jaci.2004.06.015

16.

Macfarlane

Kon

Smith

. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol. 2000;105(1 Pt 1):99–107. doi:10.1016/s0091-6749(00)90184-2

17.

Kopp

. Role of immunomodulators in allergen-specific immunotherapy. Allergy. 2011;66(6):792–797. doi:10.1111/j.1398-9995.2011.02553.x

18.

Kim

Chung

, et al. Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis. Asia Pac Allergy. 2018;8(1):e6. doi:10.5415/apallergy.2018.8.e6

19.

Ciepiela

Zawadzka-Krajewska

Kotuła

, et al. Sublingual immunotherapy for asthma: affects T-cells but does not impact basophil activation. Pediatr Allergy Immunol Pulmonol. 2014;27(1):17–23. doi:10.1089/ped.2014.0328

20.

Zidarn

Košnik

Šilar

, et al. Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study. Allergy. 2015;70(5):547–555. doi:10.1111/all.12581

21.

Ebo

Sainte-Laudy

Bridts

, et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 2006;61(9):1028–1039. doi:10.1111/j.1398-9995.2006.01039.x

22.

Reimer

Magnusson

Juremalm

, et al. Isolation of transcriptionally active umbilical cord blood—derived basophils expressing Fc epsilon RI, HLA-DR and CD203c. Allergy. 2006;61(9):1063–1070. doi:10.1111/j.1398-9995.2006.01149.x

23.

Alvarez-Cuesta

Bousquet

Canonica

, et al. Standards for practical allergen-specific immunotherapy. Allergy. 2006;61(Suppl 82):1–20. doi:10.1111/j.1398-9995.2006.01219_1.x

24.

Pilette

Nouri-Aria

Jacobson

, et al. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol. 2007;178(7):4658–4666. doi:10.4049/jimmunol.178.7.4658

25.

Long

Zeng

, et al. Long-term efficacy of standardized specific subcutaneous immunotherapy on pediatric persistent allergic rhinitis. Chin J OtorhinolaryngolHead Neck Surg. 2016;23(6):283–286.

26.

Qiu

Han

, et al. Study on influential factors associated with the long-term effect of allergic rhinitis specific immunotherapy. J Clin Otorhinolaryngol. 2015;29(3):215–218.

27.

Jacobsen

Niggemann

Dreborg

, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62(8):943–948. doi:10.1111/j.1398-9995.2007.01451.x